Newsletter | July 8, 2025

07.08.25 -- The Potential Impact Of U.S. Tariffs On The Biotech Sector

SPONSOR

Join CHI's 8th Annual SCOPE Europe in Barcelona for three days of clinical operations innovation. Explore six conferences, 50 exhibitors, and cutting-edge case studies. Network with 700+ senior executives from 300 organizations across 30 countries, including Pharma, Biotech, CROs, tech providers, and more. Attend keynotes, panels, and breakouts focused on clinical trial excellence. Don’t miss this premier event driving the future of clinical research and operations. www.SCOPEsummitEurope.com

FEATURED EDITORIAL

The Potential Impact Of U.S. Tariffs On The Biotech Sector: Manufacturing, Funding, And Clinical Trials

Syner-G Biopharma Group's Raymond Forslund, Ph.D., MBA explores how U.S. tariffs might affect biotech manufacturing, funding, and clinical research.

INDUSTRY INSIGHTS

Building Robust Clinical Supply Chains To Support Global Trials

Ensuring drugs reach patients at the right time and place is crucial. Review key areas to consider as you build a robust clinical supply chain that supports global trials effectively and efficiently.

Outlook 2025: Key Trends & Insights

Dive into the key trends and challenges shaping the year ahead, from geopolitical uncertainties to cutting-edge innovation in AI, oncology, and weight-loss therapies.

Critical Supply Strategies For CROs

Leveraging the expertise of a chosen clinical supply partner can be a valuable resource. Examine key considerations when partnering with a CRO in order to deliver a successful clinical supply strategy.

SPONSOR

Webinar: Fixing the Monitoring Model: How a Flexible Resource Supports Trial Success

As clinical trials grow increasingly complex, traditional monitoring models are showing their cracks. Overextended CRAs, inconsistent site engagement, and reactive oversight can lead to delays, data quality issues, and strained site relationships. Join clinical operations experts for a candid conversation about what's not working in today’s trial monitoring—and what could.

SOLUTIONS

Innovations In IRT